NSE: SANOFI | BSE: 500674

Mid-range Performer

Download real time

5018.00 -19.50 (-0.39%)

Near 52W Low of ₹4902.00

11,496 NSE+BSE Volume

NSE 22 Sep, 2025 3:31 PM (IST)

11,556.8

Market Cap

High in industry

0.4

Beta 1Year

Very Low volatility

Sanofi India Ltd. share price target and research reports

Name: Latest research reports of Sanofi India Ltd. authored by Angel Broking and published by - Trendlyne research reports.
Item: Sanofi India Ltd.
Rating: 3
Author: Angel Broking

Latest analyst research reports with target prices and PDF download for SANOFI, BSE:500674 Sanofi India Ltd.

Sanofi India Ltd.

10 Nov 2016

5018.00

-0.39%

Sanofi India posted results and are below expectations on all fronts. The sales came in at Rs583cr vs. Rs600cr expected, posting a yoy growth of 5.4%. According to AIOCD, secondary sales, growth for Sanofi India was double digit. According to AIOCD, regulatory actions will have negative one-time impact of ~2% on sales of the company. We e..

Sanofi India Ltd. is trading below all available SMAs

Sanofi India Ltd.

06 May 2016

5018.00

-0.39%

Sanofi India Ltd

Accumulate: Sanofi India Ltd.

Angel Broking

Sanofi India (Sanofi)'s 1QCY2016 results have come in lower than our expectation; the company posted a 10.1% yoy growth in revenue to Rs506cr V/s an expected Rs593cr. On the operating front, the gross margin came in at 52.1%, almost in line with our expectation, and V/s 47.8% in the corresponding period of last year. The OPM came in at 18..

Sanofi India Ltd. has lost -30.40% in the last 1 Year

Sanofi India Ltd.

29 Apr 2016

5018.00

-0.39%

Sanofi India: Revenue in line, EBITDA margin surprises positively

Buy: Sanofi India Ltd.

Motilal Oswal

Double-digit sales growth for third consecutive quarter: Sanofi reported a double-digit growth of 11.4% YoY for the third consecutive quarter since 2QCY15, aided to some extent by higher other operating income of INR637m,...

Sanofi India Ltd. is trading below all available SMAs

Sanofi India Ltd.

01 Dec 2015

5018.00

-0.39%

Sanofi India Ltd.

Buy: Sanofi India Ltd.

Ashika Research

Sanofi India Ltd. (Sanofi) is a 60.4% subsidiary of Hoechst, Germany (subsidiary of Sanofi SA). Sanofi India Ltd (Sanofi India) is an active pharmaceutical ingredient (API) and formulations...

Sanofi India Ltd. has lost -30.40% in the last 1 Year

Sanofi India Ltd.

22 Jul 2015, 12:00AM

5018.00

-0.39%

Sanofi India: Q2CY15 Result Review - Margins Outperform (Jul 22, 2015)

Sell: Sanofi India Ltd.

Karvy

Sanofi's total revenues increased by 8.7 % YoY to Rs 5.5 bn in Q2CY15 lower than our estimates of Rs 5.8 bn. Operating margins were a major surprise as it moved up from 19.4 % to 22.1% (higher than our estimate of 19.1%). Savings in overheads and employee expenses were the key margin contributors. Net Profit grew by 11.7% YoY to Rs 642 mn as against our estimates of Rs 420 mn.

Sanofi India Ltd. is trading below all available SMAs

Is Sanofi India Ltd. worth buying?

295 Votes:

Buy 79.66%

Sell 11.19%

Hold 9.15%